Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read more
Tuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read more
Access to medicines
February 6, 2019Unaffordable, unavailable, not adapted - people around the world face these challenges in accessing lifesaving medicines. During the 1990s, MSF teams made a bitter observation: we were failing to treat some of our patients suffering from infectious diseases, while in...
Read more
Access Campaign
January 28, 2019MSF in India: Projects in IndiaAccess campaign Connect with us MSF strengthening commitment to access to products for healthcare New structure will continue vital work to improve access to products for healthcare for people who need them most.Driven by a...
Read more
ASEAN and India urged not to trade away people’s lives in trade agreement
July 20, 2018RCEP trade deal could cut medicines lifeline for people in developing countries Bangkok/Geneva - As the sixteen countries negotiating Regional Comprehensive Economic Partnership (RCEP) trade agreement meet in Bangkok this week for another round of closed-door negotiations, public health experts and...
Read more
People living with hepatitis C and HIV challenge evergreening patents on lifesaving hepatitis C drugs in India
July 10, 2018Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes two patent oppositions filed by Delhi Network of Positive People (DNP+) before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Sciences for the hepatitis C medicines sofosbuvir and velpatasvir....
Read more
Medicines Shouldn’t be a Luxury
September 3, 2013Name : Designation : What if the medicines that could save your life cost a hundred times what you earn in a year? Many people in developing countries can’t get hold of the treatment they need to stay alive and...
Read more
